−1.35TWD
−38.17 MTWD
20.20 MTWD
18.18 M
About SYNCORE BIOTECHNOL
Sector
CEO
Mu Huan Su
Headquarters
Yilan
Website
Founded
2008
ISIN
TW0004192000
FIGI
BBG00553G5T6
SynCore Biotechnology Co., Ltd. is a biopharmaceutical company. It engages in the business of new drug developing and selling, food advisory, medicine inspection, biotechnology service, and intellectual property. The company was founded by Chih Wen Li on June 26, 2008 and is headquartered in Yilan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4192 is 47.80 TWD — it has increased by 5.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SYNCORE BIOTECHNOL stocks are traded under the ticker 4192.
SYNCORE BIOTECHNOL is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4192 stock is 5.34% volatile and has beta coefficient of −0.25. Check out the list of the most volatile stocks — is SYNCORE BIOTECHNOL there?
Yes, you can track SYNCORE BIOTECHNOL financials in yearly and quarterly reports right on TradingView.
4192 stock has risen by 1.38% compared to the previous week, the month change is a 28.49% rise, over the last year SYNCORE BIOTECHNOL has showed a 33.47% decrease.
4192 net income for the last quarter is 41.62 M TWD, while the quarter before that showed −29.47 M TWD of net income which accounts for 241.23% change. Track more SYNCORE BIOTECHNOL financial stats to get the full picture.
Today SYNCORE BIOTECHNOL has the market capitalization of 1.56 B, it has increased by 20.78% over the last week.
No, 4192 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4192 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNCORE BIOTECHNOL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNCORE BIOTECHNOL technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNCORE BIOTECHNOL stock shows the sell signal. See more of SYNCORE BIOTECHNOL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNCORE BIOTECHNOL EBITDA is −77.52 M TWD, and current EBITDA margin is −127.95%. See more stats in SYNCORE BIOTECHNOL financial statements.